Vicente Felipo Orts-rekin lankidetzan egindako argitalpenak (9)

2022

  1. Hyperammonemia Alters the Function of AMPA and NMDA Receptors in Hippocampus: Extracellular cGMP Reverses Some of These Alterations

    Neurochemical Research, Vol. 47, Núm. 7, pp. 2016-2031

  2. Intracellular and extracelluar cyclic GMP in the brain and the hippocampus

    Vitamins and Hormones (Academic Press Inc.), pp. 247-288

2020

  1. Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: Reversed by anti-TNF-α treatment

    Journal of Hepatology, Vol. 73, Núm. 3, pp. 582-592

2019

  1. Chronic hyperammonemia alters extracellular glutamate, glutamine and GABA and membrane expression of their transporters in rat cerebellum. Modulation by extracellular cGMP

    Neuropharmacology, Vol. 161

  2. Differential role of interleukin-1β in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats

    FASEB Journal, Vol. 33, Núm. 9, pp. 9913-9928

  3. Extracellular cGMP Reverses Altered Membrane Expression of AMPA Receptors in Hippocampus of Hyperammonemic Rats: Underlying Mechanisms

    Molecular Neurobiology, Vol. 56, Núm. 6, pp. 4428-4439

  4. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications

    Acta Physiologica, Vol. 226, Núm. 2

2018

  1. Chronic hyperammonemia alters in opposite ways membrane expression of GluA1 and GluA2 AMPA receptor subunits in cerebellum. Molecular mechanisms involved

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 1, pp. 286-295

  2. Hyperammonemia alters membrane expression of GluA1 and GluA2 subunits of AMPA receptors in hippocampus by enhancing activation of the IL-1 receptor: Underlying mechanisms

    Journal of Neuroinflammation, Vol. 15, Núm. 1